2024年8月9日
Here, we describe different multicellular spheroid formation methods to perform follow-up multi-parameter live cell microscopy. Using fluorescence lifetime imaging microscopy (FLIM), cellular autofluorescence, staining dyes, and nanoparticles, the approach for analysis of cell metabolism, hypoxia, and cell death in live three-dimensional (3D) cancer and stem cell-derived spheroids is demonstrated.
In this work, we present and compare spheroid formation methods that can be used for analysis of cell metabolism and oxygen distribution using live cell microscopy. In recent years, fluorescence lifetime imaging microscopy has been extensively used to investigate metabolic biomarkers like NADPH and FAD in live cells, and several fluorescent nanoparticles have been developed to multiplex such measurements with imaging of cell and tissue oxygenation. Multicellular spheroids, organoids, and organ-on-a-chip can replicate a complex, in-vivo-like microenvironment, minimizing the need in animal research.
For spheroid production, we show different formation methods, can span from low to high throughput. They also highlight their optical accessibility, compatibility with fluorescence lifetime imaging microscope, and the possibility of including extracellular matrix components. So, even though 3D in vitro models provide better context in comparison to 2D cultures, their high variability, low reproducibility, and incomplete experimental reporting remain a problem.
Parameters such as the spheroid size, the nutrient composition, the extracellular viscosity, and even spheroid formation methods can all lead to increased cellular heterogeneity. With this protocol, we aim to harmonize and standardize the spheroid production methods, highlighting key aspects important for life-continuous and multiparametric analysis of spheroids using FLIM microscopy.
本文介绍了多种形成多细胞球体的方法,用于通过活细胞显微镜分析细胞代谢和氧气分布。研究重点利用荧光寿命成像显微技术(FLIM)来检测活细胞中的代谢生物标志物。
多细胞球体的标准化制备与多参数荧光寿命成像分析(FLIM)可解决药物发现中肿瘤微环境建模的关键挑战。通过统一球体形成与活细胞成像工作流程,可提高代谢和缺氧相关读数的预测可靠性,支持早期阶段的稳健决策。该方法增强了转化研究的连续性,并降低了肿瘤学与干细胞研发项目中的生物学风险。
该标准化工作流程整合了从早期发现到先导物识别及临床前验证的各个环节,利用标准化的球状体生产和荧光寿命成像分析技术(FLIM)实现高效分析。